drugset / Trial / NCT00312663
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America
Phase 1/2
Completed
24 enrolled
U.S. Army Medical Research and Development Command
GlaxoSmithKline · collabThe PATH Malaria Vaccine Initiative (MVI) · collabWalter Reed Army Institute of Research (WRAIR) · collab
RandomizedSingle-groupOpen-labelPrevention
Summary
Phase I/II Trial of a Malaria Vaccine, FMP011/AS01B, in Adults Living in the United States of America.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-10
- Completion
- 2007-04